EPS and Revenue Analysis (TTM & YoY Basis)
| Metric | Value | Assessment |
|---|---|---|
| EPS (TTM) | €6.65 | Solid absolute earnings base |
| EPS Growth YoY | +1,434.64% | Exceptional recovery or base comparison effect; extraordinary growth rate |
| Revenue Growth YoY | −4.91% | Revenue headwinds; chemical sector cyclicality evident |
| Forward P/E | 17.17x | Below trailing P/E (28.89x); implies forward earnings expansion |
Extraordinary YoY EPS growth (+1,434.64%) suggests a dramatic recovery from a depressed prior-year base or significant one-time benefit realization. However, this masks underlying revenue contraction (−4.91% YoY), indicating margin expansion rather than organic top-line strength. The chemical sector faces demand headwinds. Forward P/E compression (17.17x vs. 28.89x trailing) reflects market expectations of sustained profitability, though guidance and earnings dates remain undisclosed.
Profitability Metrics & Quality Assessment
| Metric | Value | Status |
|---|---|---|
| EPS | €6.65 | Strong absolute profitability per share |
| P/E Ratio (Trailing) | 28.89x | Premium valuation for chemicals sector |
| Dividend Yield | 7.63% | Attractive income; €2.35/share annual dividend |
| PEG Ratio | 0.020 | Exceptional growth-adjusted valuation |
| Gross/Op/Net Margin | Data constrained | Limited visibility; inferred strong net margins from EPS/market cap |
| ROE / ROIC | Data constrained | Not disclosed; assess via dividend yield and EPS quality |
BASF demonstrates strong absolute profitability (€6.65 EPS) backed by a 7.63% dividend yield, signaling confident capital returns. The PEG ratio of 0.020 is exceptionally low, indicating earnings growth substantially outpaces valuation. However, the absence of detailed margin and return-on-capital data limits full quality assessment. The revenue decline YoY suggests operational headwinds in underlying business fundamentals, offset by cost discipline.
Financial Position & Leverage Assessment
| Metric | Value / Status | Implication |
|---|---|---|
| Cash & Liquidity | Data constrained | Not disclosed in available financials; material gap for large-cap assessment |
| Total Debt / Net Debt | Data constrained | Limited visibility; €46.7B market cap suggests substantial debt base typical for diversified chemical conglomerate |
| Net Debt/EBITDA | Data constrained | Not disclosed; material metric for cyclical sector |
| Interest Coverage | Data constrained | Unable to assess; critical gap for debt servicing capacity |
| Current Ratio | Data constrained | Not disclosed; operational liquidity assessment limited |
| Beta | 0.301 | Low systematic risk; defensive profile |
| Shareholder Dilution | Data constrained | No recent dilution flags evident; stable share structure assumed |
Coverage is materially constrained by missing balance sheet and cashflow statements. BASF's low beta (0.301) indicates resilient, defensive market positioning. As a large-cap industrial conglomerate, typical leverage metrics warrant scrutiny in a cyclical downturn environment (evidenced by −4.91% revenue YoY). The 7.63% dividend yield maintained during revenue contraction signals confidence in cash generation, but detailed debt structure and liquidity buffers remain opaque.
Valuation Multiples & Relative Assessment
| Metric | Value | Assessment vs. Sector |
|---|---|---|
| Trailing P/E | 28.89x | Premium to chemicals sector median (~15–18x); elevated |
| Forward P/E | 17.17x | In-line with sector; near-term earnings expansion priced in |
| PEG Ratio | 0.020 | Deeply attractive; exceptional growth-adjusted value |
| Price / Sales | Data constrained | Revenue TTM not disclosed; unable to calculate |
| EV / EBITDA | Data constrained | Not disclosed; enterprise value available but EBITDA missing |
| Dividend Yield | 7.63% | Attractive absolute yield; provides valuation floor & income support |
BASF trades at a premium trailing P/E (28.89x) reflective of earnings recovery premium, but forward P/E (17.17x) suggests mean reversion toward sector norms. The extraordinary PEG ratio (0.020) indicates the market underprices growth relative to valuation—a potential value opportunity if +1,434% EPS growth proves sustainable. The 7.63% dividend yield acts as a valuation anchor and return floor. However, structural revenue weakness (−4.91% YoY) and sector cyclicality warrant cautious interpretation of multiple expansion sustainability.
Wall Street Research & Price Targets
| Metric | Value | Implication |
|---|---|---|
| Consensus Rating | Data constrained | Not disclosed; analyst coverage not available in dataset |
| Price Target (Mean) | Data constrained | Not disclosed; target_price_mean returns null |
| Price Target (High) | Data constrained | Not disclosed; no consensus high estimate |
| Price Target (Low) | Data constrained | Not disclosed; no consensus low estimate |
| Implied Upside / Downside | Data constrained | Unable to calculate without consensus targets |
| Target Dispersion | Data constrained | Not disclosed; analyst consensus breadth unknown |
Detailed analyst research coverage is unavailable in the current dataset. Price targets, consensus ratings, and research dispersion metrics are not disclosed, preventing quantitative sentiment assessment. This represents a material gap for institutional decision-making. Based on public market behavior (52W return of +20.85% and current forward P/E of 17.17x), the market appears cautiously constructive, pricing in earnings normalization rather than consensus upside surprise.
Ownership, Insider Activity & Risk Flags
| Factor | Status / Value | Risk Assessment |
|---|---|---|
| Institutional Ownership Trend | Data constrained | Not disclosed; large-cap XETRA listing typically held widely by EU institutions |
| Insider Buying / Selling | Data constrained | Not disclosed; material signal unavailable |
| Short Interest | Data constrained | Not disclosed; cannot assess bearish sentiment or short squeeze risk |
| High Valuation Flag | FALSE | System assessment: valuation not extreme despite P/E premium |
| Hyper-Growth Flag | FALSE | Despite +1,434% EPS growth, revenue decline prevents hyper-growth classification |
| Strong Profitability Flag | FALSE | Adequate earnings (6.65 EPS) but modest relative to market cap; margin data unavailable |
| Weak Balance Sheet Flag | FALSE | Low beta (0.301) and sustained dividend suggest stable financial position |
| Cyclical Sector Risk | ELEVATED | Chemicals sector in contraction (−4.91% revenue YoY); macro sensitivity high |
| Earnings Sustainability Risk | MODERATE-HIGH | +1,434% EPS growth likely unsustainable; base comparison effect or one-time gains probable |
BASF carries moderate-to-elevated risk profile driven by cyclical chemical sector exposure (evidenced by −4.91% revenue contraction), extraordinary but likely non-sustainable earnings growth (+1,434% YoY), and material data gaps in balance sheet detail. Institutional ownership and insider flow data are unavailable, limiting sentiment triangulation. The system's absence of red flags on valuation, growth, profitability, and balance sheet suggests baseline financial stability, but structural headwinds in the sector warrant caution. Low beta (0.301) provides downside mitigation.
Supported by strong dividend yield (7.63%), attractive forward P/E (17.17x), and exceptional PEG ratio (0.020). Tempered by structural revenue weakness (−4.91% YoY), extraordinary but potentially unsustainable EPS growth (+1,434%), and material data gaps in financial detail (balance sheet, cashflow, earnings guidance).
- Earnings Recovery Play: +1,434% YoY EPS growth, though likely cyclical/base-driven; forward P/E (17.17x) implies earnings normalization expectations embedded.
- Dividend Fortress: 7.63% yield with €2.35/share payout maintained despite −4.91% revenue contraction; signals strong dividend policy and cash generation confidence.
- Valuation Opportunity: PEG ratio of 0.020 is exceptionally compelling; forward P/E near sector median (17.17x) suggests downside-protected entry for 6–12M horizon.
- Sector Cyclicality Risk: Chemical industry headwinds evident in revenue decline; macro sensitivity elevated; low beta (0.301) provides defensive hedge but does not offset industry structural challenges.
- Data Gaps Require Monitoring: Balance sheet detail, cashflow trends, earnings guidance, and analyst targets unavailable; recommend accessing full financial statements and Q-earnings releases before material position increases.
BASFY Stock Analysis & Forecast
Is BASFY a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
BASFY Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, BASFY shows balanced risk-reward characteristics.
Should You Buy BASFY Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in BASFY.